Effects of a parallel-arm randomized controlled weight loss pilot study on biological and psychosocial parameters of overweight and obese breast cancer survivors

被引：9
作者：
Arikawa A.Y. [1 ]
Kaufman B.C. [2 ]
Raatz S.K. [3 ]
Kurzer M.S. [2 ]
机构：
[1] University of North Florida, Department of Nutrition and Dietetics, Jacksonville, FL - 1 UNF Drive, Jacksonville, 32224, FL
[2] University of Minnesota, Department of Food Science and Nutrition, St. Paul, MN - 1334 Eckles Ave, Saint Paul, 55108, MN
[3] USDA-ARS, Grand Forks, Grand Forks Human Nutrition Research Center, ND - 2420 2nd Avenue North, Grand Forks, 58206, ND
来源：
Pilot and Feasibility Studies | / 4卷 / 1期
关键词：
Breast cancer; Diet; Obesity; Physical activity; Survivorship; Weight loss;
D O I：
10.1186/s40814-017-0160-9
中图分类号：
学科分类号：
摘要：
Background: Weight gain often occurs after breast cancer (BC) diagnosis and obesity along with sedentary behavior are associated with increased risk of BC recurrence and mortality. The primary objective of this study was to determine whether a significant weight loss, of approximately 10%, would lead to beneficial changes in biomarkers associated with cancer and/or cancer recurrence, and quality of life (QOL) in overweight and obese BC survivors. Methods: This parallel-arm study took place in Minneapolis, Minnesota, from January 2009 until March 2010. Participants were overweight and obese postmenopausal BC survivors who had completed treatment at least 3 months prior to enrollment and who did not smoke. Twenty-one BC survivors were randomized, via a random number generator computer software, to a 1000-calorie deficit feeding and exercise intervention (CR) or a weight management counseling intervention (WM) for 12 weeks followed by a 6-week follow-up. Body weight, biomarkers, and QOL were measured at baseline, weeks 6, 12, and 18. Body composition and fitness level were measured at only two time points. Results: Twenty-one women were enrolled into the study and 20 completed all time points. Weight loss occurred with both interventions. Body weight in CR changed from 85.5 (95% confidence interval (CI) 77, 94) kg to 76.7 (95% CI 68.1, 85.2) kg, whereas in WM it changed from 98.3 (95% CI 89.8, 106.8) kg to 93.2 (95% CI 84.6, 101.7) kg. Fitness in CR changed from 4.9 (95% CI 4, 5.8) to 6.3 (95% CI 5.4, 7.2). CR led to lower plasma levels of leptin, F2-isoprostanes, and CRP. Quality of life seemed to improve with both interventions, while sleep quality decreased only in CR. Conclusions: Overweight and obese BC survivors were able to adhere to a strict diet and exercise program, which significantly decreased body weight, increased fitness level, and improved biomarkers and QOL. However, the strict dietary intervention in CR seemed to decrease participants' sleep quality and social relationships. Future larger randomized controlled trials should focus on behavioral modification and personalized nutrition counseling to help breast cancer survivors achieve a sustainable weight loss and fitness level. © 2017 The Author(s).
引用
收藏
相关论文
共 67 条
  • [11] Irwin M.L., Alvarez-Reeves M., Cadmus L., Mierzejewski E., Mayne S.T., Yu H., Chung G.G., Jones B., Knobf M.T., DiPietro L., Exercise improves body fat, lean mass, and bone mass in breast cancer survivors, Obesity (Silver Spring), 17, pp. 1534-1541, (2009)
  • [12] McTiernan A., Obesity and cancer: the risks, science, and potential management strategies, Oncology (Williston Park), 19, pp. 871-881, (2005)
  • [13] Goodwin P.J., Ennis M., Pritchard K.I., Trudeau M.E., Koo J., Madarnas Y., Hartwick W., Hoffman B., Hood N., Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study, J Clin Oncol, 20, pp. 42-51, (2002)
  • [14] Albuquerque K.V., Price M.R., Badley R.A., Jonrup I., Pearson D., Blamey R.W., Robertson J.F., Pre-treatment serum levels of tumour markers in metastatic breast cancer: a prospective assessment of their role in predicting response to therapy and survival, Eur J Surg Oncol, 21, pp. 504-509, (1995)
  • [15] Al Murri A.M., Bartlett J.M., Canney P.A., Doughty J.C., Wilson C., McMillan D.C., Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer, Br J Cancer, 94, pp. 227-230, (2006)
  • [16] Al Murri A.M., Wilson C., Lannigan A., Doughty J.C., Angerson W.J., McArdle C.S., McMillan D.C., Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer, Br J Cancer, 96, pp. 891-895, (2007)
  • [17] Lohmann A.E., Goodwin P.J., Chlebowski R.T., Pan K., Stambolic V., Dowling R.J., Association of obesity-related metabolic disruptions with cancer risk and outcome, J Clin Oncol, 34, pp. 4249-4255, (2016)
  • [18] Sephton S., Spiegel D., Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease?, Brain Behav Immun, 17, pp. 321-328, (2003)
  • [19] Sephton S.E., Sapolsky R.M., Kraemer H.C., Spiegel D., Diurnal cortisol rhythm as a predictor of breast cancer survival, J Natl Cancer Inst, 92, pp. 994-1000, (2000)
  • [20] Bartsch C., Kvetnoy I., Kvetnaia T., Bartsch H., Molotkov A., Franz H., Raikhlin N., Mecke D., Nocturnal urinary 6-sulfatoxymelatonin and proliferating cell nuclear antigen-immunopositive tumor cells show strong positive correlations in patients with gastrointestinal and lung cancer, J Pineal Res, 23, pp. 90-96, (1997)
1234567